Pharming Group (OTCMKTS:PHGUF – Get Free Report) crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.90 and traded as low as $0.87. Pharming Group shares last traded at $0.87, with a volume of 1,000 shares trading hands.
Pharming Group Stock Performance
The company has a market cap of $582.83 million, a PE ratio of -43.43 and a beta of 1.00. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.76 and a current ratio of 3.53. The firm’s 50 day moving average is $0.90 and its 200-day moving average is $0.83.
About Pharming Group
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Read More
- Five stocks we like better than Pharming Group
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- How to Invest in Insurance Companies: A Guide
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Retail Stocks Investing, Explained
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
